Skip to main content

Table 3 The mean tumour necrosis factor α (TNF-α), nuclear factor kappa β (NFK-β), and interleukin 6 (IL-6) expressions according to experimental groups

From: Does the cardiovascular drug levosimendan prevent iodinated contrast medium nephrotoxicity with glycerol aggravation in rats?

  TNF-α (expressions relative to β-actin) NFK-β (expressions relative to β-actin) IL-6 (expressions relative to β-actin)
Groups Mean Standard deviation Mean Standard deviation Mean Standard deviation
Healthy (I) 2.150 0.105 2.417 0.147 3.300 0.179
GLY (II) 9.317 0.232 11.333 0.216 13.250 0.188
CM (III) 2.300 0.141 2.450 0.164 3.200 0.110
GLY+CM (IV) 20.350 0.207 25.367 0.207 30.183 0.117
CM+LEVO 0.25 (V) 2.633 0.137 2.517 0.075 3.300 0.141
GLY+CM+LEVO 0.25 (VI) 7.167 0.103 8.167 0.103 10.333 0.216
CM+LEVO 0.5 (VII) 2.517 0.147 2.683 0.147 3.350 0.187
GLY+CM+LEVO 0.5 (VIII) 5.367 0.163 5.183 0.117 5.250 0.187
  1. CM Contrast medium, GLY Glycerol, IL-6 Interleukin 6, LEVO Levosimendan, NFK-ß Nuclear factor kappa ß, TNF-α Tumour necrosis factor α